You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 10,261,083


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,261,083
Title:Compositions and methods for detecting protease activity in biological systems
Abstract: The invention relates generally to compositions and methods for detecting protease activity in a subject or a biological sample using activatable antibodies, and the use of these compositions and methods in a variety of diagnostic indications.
Inventor(s): Vasiljeva; Olga (Cupertino, CA), Menendez; Elizabeth-Edna Mary (San Mateo, CA)
Assignee: CytomX Therapeutics, Inc. (South San Francisco, CA)
Application Number:14/147,324
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of U.S. Patent 10,261,083: A Detailed Analysis

Introduction

U.S. Patent 10,261,083, titled "Compositions and methods for detecting protease activity in biological systems," is a patent that delves into innovative methods and compositions for detecting protease activity. This analysis will explore the patent's scope, claims, and the broader patent landscape, highlighting key aspects and implications.

Patent Overview

Inventorship and Ownership

The patent lists specific inventors who conceived and reduced the idea to practice, a critical aspect under U.S. patent law. Correctly determining inventorship is paramount, as misidentification can lead to patent invalidation[2].

Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention. For U.S. Patent 10,261,083, the claims outline specific compositions and methods for detecting protease activity. These claims must be clear, concise, and exact to meet statutory requirements[1].

Scope of the Patent

Independent Claim Length and Count

The scope of a patent can be measured using metrics such as independent claim length and count. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Claim Language and Clarity

The clarity of claim language is crucial for patent quality. The USPTO has emphasized the importance of clear and concise terms in patent applications to avoid issues during examination and potential litigation. The claims in U.S. Patent 10,261,083 must adhere to these standards to ensure their validity[1].

Claims Analysis

Independent Claims

Independent claims in the patent define the core inventions without reference to other claims. These claims are critical as they set the boundaries of the patent's protection.

Dependent Claims

Dependent claims build upon the independent claims, providing additional details and limitations. They help in narrowing down the scope and can be used to differentiate the invention from prior art.

Patent Landscape

Patent Quality and Examination Process

The USPTO has been working to improve patent quality through initiatives such as the Enhanced Patent Quality Initiative. This includes reassessing the time allotted for examination and analyzing the effects of incentives on patent quality. These efforts aim to ensure that patents, like U.S. Patent 10,261,083, meet statutory requirements and are upheld if challenged[1].

Forward Citations and Novelty

Forward citations, which are citations to the patent by later patents, can indicate the impact and novelty of the invention. A higher number of forward citations often suggests that the patent is influential in its field. The novelty of the methods and compositions described in U.S. Patent 10,261,083 would be reflected in its forward citations and the breadth of patent classes it falls under[3].

Legal and Administrative Considerations

Inventorship Corrections

Errors in inventorship can be corrected, but such corrections must be made without deceptive intent. Any intentional misrepresentation can render the patent unenforceable. Ensuring the correct inventors are listed from the outset is essential to avoid future legal complications[2].

Claim Amendments and Changes in Inventorship

During the prosecution of the patent application, claim amendments can result in changes to inventorship. This is particularly relevant if claims are canceled or modified, which may necessitate the removal or addition of inventors[2].

Industry Impact and Innovation

Innovation Incentives

The clarity and scope of patents like U.S. Patent 10,261,083 can significantly impact innovation. Clear and valid patents can encourage further research and development by providing clear boundaries and incentives for licensing and collaboration[3].

Licensing and Litigation Costs

Overly broad or unclear patents can lead to increased licensing and litigation costs, which can diminish innovation. The narrower and clearer claims in U.S. Patent 10,261,083 help mitigate these issues, fostering a more conducive environment for innovation[3].

Key Takeaways

  • Clear Claims: The patent's claims must be clear, concise, and exact to ensure validity and avoid legal issues.
  • Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope and predicting the likelihood of grant and examination duration.
  • Inventorship: Correct determination of inventorship is crucial to avoid patent invalidation.
  • Patent Quality Initiatives: The USPTO's efforts to improve patent quality are essential for maintaining the integrity and effectiveness of the patent system.
  • Industry Impact: Clear and valid patents can encourage innovation by providing clear boundaries and reducing licensing and litigation costs.

FAQs

What is the significance of clear claim language in patent applications?

Clear claim language is essential to ensure that the patent meets statutory requirements and can be upheld if challenged. It helps in avoiding issues during examination and potential litigation[1].

How does the USPTO measure patent quality?

The USPTO measures patent quality through various metrics, including compliance rates for statutory requirements and the use of correctness measures. It also analyzes the effects of incentives and examination processes on patent quality[1].

What are the consequences of incorrect inventorship in a patent application?

Incorrect inventorship can lead to patent invalidation if done with deceptive intent. Even without deceptive intent, corrections can be administratively costly and may raise red flags in future litigation[2].

How do forward citations reflect the impact of a patent?

Forward citations indicate the influence and novelty of a patent. A higher number of forward citations suggests that the patent is significant and has contributed to further innovation in its field[3].

Why is the scope of a patent important?

The scope of a patent defines the boundaries of the invention's protection. Narrower and clearer claims can facilitate innovation by reducing licensing and litigation costs and providing clear incentives for further research and development[3].

More… ↓

⤷  Subscribe

Details for Patent 10,261,083

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 ⤷  Subscribe 2033-01-04
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 ⤷  Subscribe 2033-01-04
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 ⤷  Subscribe 2033-01-04
Akorn, Inc. HYDASE hyaluronidase Injection 021716 October 25, 2005 ⤷  Subscribe 2033-01-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.